Aptevo Therapeutics (APVO) Non-Current Assets (2016 - 2023)
Historic Non-Current Assets for Aptevo Therapeutics (APVO) over the last 9 years, with Q3 2023 value amounting to $6.0 million.
- Aptevo Therapeutics' Non-Current Assets fell 1517.59% to $6.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $25.5 million, marking a year-over-year increase of 1573.64%. This contributed to the annual value of $6.8 million for FY2022, which is 6782.44% up from last year.
- Per Aptevo Therapeutics' latest filing, its Non-Current Assets stood at $6.0 million for Q3 2023, which was down 1517.59% from $6.2 million recorded in Q2 2023.
- In the past 5 years, Aptevo Therapeutics' Non-Current Assets ranged from a high of $23.8 million in Q3 2019 and a low of $3.5 million during Q1 2022
- For the 5-year period, Aptevo Therapeutics' Non-Current Assets averaged around $9.9 million, with its median value being $6.8 million (2022).
- Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 7316.45% in 2020, then skyrocketed by 8462.41% in 2023.
- Aptevo Therapeutics' Non-Current Assets (Quarter) stood at $23.4 million in 2019, then tumbled by 73.16% to $6.3 million in 2020, then crashed by 35.84% to $4.0 million in 2021, then surged by 67.82% to $6.8 million in 2022, then fell by 11.26% to $6.0 million in 2023.
- Its Non-Current Assets stands at $6.0 million for Q3 2023, versus $6.2 million for Q2 2023 and $6.5 million for Q1 2023.